SCHEMBL22619085

SCHEMBL22619085

Cc1cccc(NS(=O)(=O)c2ccno2)c1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.52
LMNA P02545 4/20 0.50
HPGD P15428 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
HDAC4 P56524 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
HTT P42858 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
ALDH1A1 P00352 1/20 0.48
GAA P10253 1/20 0.48
MEN1 O00255 5/20 0.48
MAPT P10636 3/20 0.44
XBP1 P17861 1/20 0.44
PKM P14618 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22928039 0.82 MAPT (0.47) KMT2ACYP3A4CYP2C19HTTSMN1; SMN2
SCHEMBL14582133 0.74 KMT2A (0.72) KMT2ALMNAHPGDCYP3A4CYP2C9
SCHEMBL15045213 0.73 KMT2A (0.71) KMT2ALMNAHPGDHDAC1HTT
SCHEMBL19512927 0.72 HPGD (0.51) KMT2ALMNAHPGDCYP3A4CYP2C9
SCHEMBL259382 0.71 CA12 (0.66) KMT2ALMNAHPGDHTTSMN1; SMN2
SCHEMBL31681311 0.71 CA12 (0.66) KMT2ALMNAHPGDHTTSMN1; SMN2
SCHEMBL3701951 0.71 CA12 (0.71) KMT2ALMNAHPGDHTTSMN1; SMN2
SCHEMBL13875341 0.71 L3MBTL1 (0.67) KMT2ALMNAHTTSMN1; SMN2ALDH1A1
SCHEMBL12474917 0.71 KMT2A (0.65) KMT2ALMNAHTTSMN1; SMN2ALDH1A1
SCHEMBL1038559 0.71 LMNA (0.51) KMT2ALMNAHPGDCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3733670-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF Mediconns (Shanghai) Biopharmaceutical Co., Ltd (CN) 2020-11-04 EP disclosed